ACM
BIIB icon

Advent Capital Management’s Biogen BIIB Stock Holding History

Advent Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,626
Closed -$1.16M – 273
2017
Q4 		$1.16M Buy
+3,626
New +$1.16M 0.02% 177
2017
Q3 		– Sell
-15,500
Closed -$4.21M – 296
2017
Q2 		$4.21M Sell
15,500
-1,500
-9% -$397K 0.08% 156
2017
Q1 		$4.65M Hold
17,000
– – 0.09% 155
2016
Q4 		$4.82M Hold
17,000
– – 0.09% 155
2016
Q3 		$5.32M Buy
17,000
+2,000
+13% +$592K 0.08% 198
2016
Q2 		$3.63M Hold
15,000
– – 0.06% 225
2016
Q1 		$3.9M Hold
15,000
– – 0.06% 213
2015
Q4 		$4.64M Hold
15,000
– – 0.07% 218
2015
Q3 		$4.38M Buy
+15,000
New +$4.95M 0.07% 222

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Advent Capital Management's BIIB Position: Q1 2018 in Review

Advent Capital Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 3,626 shares — an estimated $1.16M sold.

Advent Capital Management first reported a position in BIIB in Q3 2015 and held it in 9 quarters. The position peaked at $5.32M in Q3 2016. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Advent Capital Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Advent Capital Management sold 3,626 Biogen shares in Q1 2018, an estimated $1.16M.
  • Advent Capital Management first reported a position in Biogen in Q3 2015 and held it in 9 quarters.
  • Advent Capital Management's Biogen position peaked at $5.32M in Q3 2016.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Advent Capital Management's 13F filing for Q1 2018, filed 11 May 2018.